More about
Ret-Altered Thyroid Cancer
News
August 26, 2020
4 min read
Save
Selpercatinib effective, safe in RET-altered thyroid cancer, NSCLC
Selpercatinib appeared to be effective and safe for patients with RET-altered medullary thyroid cancer and RET fusion-positive non-small cell lung cancer, according to results of two studies published in The New England Journal of Medicine.